Synonyms: PF06263276; [2-[6-(2-Ethyl-5-fluoro-4-hydroxyphenyl)-1H-indazol-3-yl]-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl][5-(1-piperidinyl)-2-pyrazinyl]-methanone
Molecular Formula: C31H31FN8O2
Molecular Weight: 566.63
Linear Structural Formula: C31H31FN8O2
Purity: >=98% (HPLC)
Storage: room temp
Biochem Physiol Actions: PF-06263276 is an inhibitor of the Janus kinase (JAK) enzymes 1, 2, 3 and tyrosine kinase 2 (TYK2). PF-06263276 has been investigated for the treatment of psoriasis.
Legal Information: Sold for research purposes under agreement from Pfizer Inc.